Moleculo has recently been acquired by Illumina. The Moleculo team is excited about this opportunity and is pleased to join forces with Illumina, the market leader in next-generation sequencing.
We believe this merger opens a great opportunity to further accelerate the development of Moleculo's technology and introduce products that will make a true impact in human clinical sequencing and de-novo assembly of complex genomes.
We would like to thank our existing customers for letting us work with them on a range of fascinating projects. This has been an exciting year for the entire team. We remain fully committed to provide existing customers uninterrupted access to our technology, as we get ready to launch it widely.